Adoptive cellular therapy after hematopoietic stem cell transplantation

被引：3

作者：

Vittayawacharin, Pongthep ^{[1
]}

Kongtim, Piyanuch ^{[1
]}

Chu, Yaya ^{[2
]}

June, Carl H. ^{[3
]}

Bollard, Catherine M. ^{[4
,5
]}

Ciurea, Stefan O. ^{[1
,6
]}

机构：

[1] Univ Calif Irvine, Dept Med, Hematopoiet Stem Cell Transplantat & Cellular Ther, Div Hematol Oncol, Orange, CA 92868 USA

[2] New York Med Coll, Dept Pediat, Valhalla, NY USA

[3] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA USA

[4] Childrens Natl Hosp, Ctr Canc & Immunol Res, Washington, DC USA

[5] George Washington Univ, Washington, DC USA

[6] Univ Calif Irvine, Hematopoiet Stem cell Transplant & Cellular Therap, 101 City Dr S, Bldg 200, Rm 450, Orange, CA 92868 USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2024年 / 99卷 / 05期

关键词：

DONOR LYMPHOCYTE INFUSIONS; NATURAL-KILLER-CELLS; ACUTE MYELOID-LEUKEMIA; VERSUS-HOST-DISEASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; CD34(+) PROGENITOR CELLS; MINIMAL RESIDUAL DISEASE; PROSPECTIVE PHASE-II; REGULATORY T-CELLS;

D O I：

10.1002/ajh.27204

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Effective cellular therapy using CD19 chimeric antigen receptor T-cells for the treatment of advanced B-cell malignancies raises the question of whether the administration of adoptive cellular therapy (ACT) posttransplant could reduce relapse and improve survival. Moreover, several early phase clinical studies have shown the potential beneficial effects of administration of tumor-associated antigen-specific T-cells and natural killer cells posttransplant for high-risk patients, aiming to decrease relapse and possibly improve survival. In this article, we present an in-depth review of ACT after transplantation, which has the potential to significantly improve the efficacy of this procedure and revolutionize this field. Summary of manufacturing processes for adoptive cellular therapies.image

引用

页码：910 / 921

页数：12

共 127 条

[1] Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study [J].

Abramson, Jeremy S. ;

Palomba, M. Lia ;

Gordon, Leo I. ;

Lunning, Matthew A. ;

Wang, Michael ;

Arnason, Jon ;

Mehta, Amitkumar ;

Purev, Enkhtsetseg ;

Maloney, David G. ;

Andreadis, Charalambos ;

Sehgal, Alison ;

Solomon, Scott R. ;

Ghosh, Nilanjan ;

Albertson, Tina M. ;

Garcia, Jacob ;

Kostic, Ana ;

Mallaney, Mary ;

Ogasawara, Ken ;

Newhall, Kathryn ;

Kim, Yeonhee ;

Li, Daniel ;

Siddiqi, Tanya .

LANCET, 2020, 396 (10254) :839-852

[2] Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study [J].

Barkholt, L. ;

Alici, E. ;

Conrad, R. ;

Sutlu, T. ;

Gilljam, M. ;

Stellan, B. ;

Christensson, B. ;

Guven, H. ;

Bjorkstrom, N. K. ;

Soderdahl, G. ;

Cederlund, K. ;

Kimby, E. ;

Aschan, J. ;

Ringden, O. ;

Ljunggren, H-G ;

Dilber, M. S. .

IMMUNOTHERAPY, 2009, 1 (05) :753-764

[3] Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma [J].

Baumeister, Susanne H. ;

Murad, Joana ;

Werner, Lillian ;

Daley, Heather ;

Trebeden-Negre, Helene ;

Gicobi, Joanina K. ;

Schmucker, Adam ;

Reder, Jake ;

Sentman, Charles L. ;

Gilham, David E. ;

Lehmann, Frederic F. ;

Galinsky, Ilene ;

DiPietro, Heidi ;

Cummings, Kristen ;

Munshi, Nikhil C. ;

Stone, Richard M. ;

Neuberg, Donna S. ;

Soiffer, Robert ;

Dranoff, Glenn ;

Ritz, Jerome ;

Nikiforow, Sarah .

CANCER IMMUNOLOGY RESEARCH, 2019, 7 (01) :100-112

[4] Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study [J].

Bejanyan, Nelli ;

Weisdorf, Daniel J. ;

Logan, Brent R. ;

Wang, Hai-Lin ;

Devine, Steven M. ;

de Lima, Marcos ;

Bunjes, Donald W. ;

Zhang, Mei-Jie .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (03) :454-459

[5] Ciltacabtagene autoleucel, a B-cell maturation antigendirected chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study [J].

Berdeja, Jesus G. ;

Madduri, Deepu ;

Usmani, Saad Z. ;

Jakubowiak, Andrzej ;

Agha, Mounzer ;

Cohen, Adam D. ;

Stewart, A. Keith ;

Hari, Parameswaran ;

Htut, Myo ;

Lesokhin, Alexander ;

Deol, Abhinav ;

Munshi, Nikhil C. ;

O'Donnell, Elizabeth ;

Avigan, David ;

Singh, Indrajeet ;

Zudaire, Enrique ;

Yeh, Tzu-Min ;

Allred, Alicia J. ;

Olyslager, Yunsi ;

Banerjee, Arnob ;

Jackson, Carolyn C. ;

Goldberg, Jenna D. ;

Schecter, Jordan M. ;

Deraedt, William ;

Zhuang, Sen Hong ;

Infante, Jeffrey ;

Geng, Dong ;

Wu, Xiaoling ;

Carrasco-Alfonso, Marlene J. ;

Akram, Muhammad ;

Hossain, Farah ;

Rizvi, Syed ;

Fan, Frank ;

Lin, Yi ;

Martin, Thomas ;

Jagannath, Sundar .

LANCET, 2021, 398 (10297) :314-324

[6] Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia [J].

Berrien-Elliott, Melissa M. ;

Foltz, Jennifer A. ;

Russler-Germain, David A. ;

Neal, Carly C. ;

Tran, Jennifer ;

Gang, Margery ;

Wong, Pamela ;

Fisk, Bryan ;

Cubitt, Celia C. ;

Marin, Nancy D. ;

Zhou, Alice Y. ;

Jacobs, Miriam T. ;

Foster, Mark ;

Schappe, Timothy ;

McClain, Ethan ;

Kersting-Schadek, Samantha ;

Desai, Sweta ;

Pence, Patrick ;

Becker-Hapak, Michelle ;

Eisele, Jeremy ;

Mosior, Matthew ;

Marsala, Lynne ;

Griffith, Obi L. ;

Griffith, Malachi ;

Khan, Saad M. ;

Spencer, David H. ;

DiPersio, John F. ;

Romee, Rizwan ;

Uy, Geoffrey L. ;

Abboud, Camille N. ;

Ghobadi, Armin ;

Westervelt, Peter ;

Stockerl-Goldstein, Keith ;

Schroeder, Mark A. ;

Wan, Fei ;

Lie, Wen-Rong ;

Soon-Shiong, Patrick ;

Petti, Allegra A. ;

Cashen, Amanda F. ;

Fehniger, Todd A. .

SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (633)

[7] Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells [J].

Boissel, Laurent ;

Tuncer, Hande H. ;

Betancur, Monica ;

Wolfberg, Adam ;

Klingemann, Hans .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (09) :1031-1038

[8] IL-2 Stimulated but Not Unstimulated NK Cells Induce Selective Disappearance of Peripheral Blood Cells: Concomitant Results to a Phase I/II Study [J].

Brehm, Claudia ;

Huenecke, Sabine ;

Quaiser, Andrea ;

Esser, Ruth ;

Bremm, Melanie ;

Kloess, Stephan ;

Soerensen, Jan ;

Kreyenberg, Hermann ;

Seidl, Christian ;

Becker, Petra S. A. ;

Muehl, Heiko ;

Klingebiel, Thomas ;

Bader, Peter ;

Passweg, Jakob R. ;

Schwabe, Dirk ;

Koehl, Ulrike .

PLOS ONE, 2011, 6 (11)

[9] Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease [J].

Brudno, Jennifer N. ;

Somerville, Robert P. T. ;

Shi, Victoria ;

Rose, Jeremy J. ;

Halverson, David C. ;

Fowler, Daniel H. ;

Gea-Banacloche, Juan C. ;

Pavletic, Steven Z. ;

Hickstein, Dennis D. ;

Lu, Tangying L. ;

Feldman, Steven A. ;

Iwamoto, Alexander T. ;

Kurlander, Roger ;

Maric, Irina ;

Goy, Andre ;

Hansen, Brenna G. ;

Wilder, Jennifer S. ;

Blacklock-Schuver, Bazetta ;

Hakim, Frances T. ;

Rosenberg, Steven A. ;

Gress, Ronald E. ;

Kochenderfer, James N. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (10) :1112-+

[10]

Budde L, 2017, BLOOD, V130

← 1 2 3 4 5 6 7 8 9 10 →